Exercise eases menopause symptoms and boosts heart health in new study
NCT ID NCT07615790
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a structured exercise program can improve heart rate variability (a measure of heart health), reduce menopausal symptoms, and enhance sleep and quality of life in postmenopausal women aged 45 to 65. Forty women will either join a supervised 12-week exercise program (2 sessions per week, 45 minutes each) or continue their usual activities. The goal is to see if simple, regular exercise can make a real difference in how women feel during menopause.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 40 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Apr 2026
- Expected to finish
-
Sep 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
45 to 65 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Women in the postmenopausal period * Aged between 45 and 65 years * Able to communicate and cooperate with the researchers * Not participating in another structured exercise program * Willing to participate voluntarily in the study Exclusion Criteria: * Presence of severe cardiovascular, neurological, orthopedic, or psychiatric disease * Hormone replacement therapy use during the study period * Cognitive impairment affecting participation * Uncontrolled hypertension or other unstable medical conditions * Regular participation in structured exercise training within the last 6 months * Smoking or alcohol use that may affect heart rate variability measurements
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Autonomic nervous system diseases are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Fenerbahce University
RECRUITINGIstanbul, Atasehir, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Two estradiol dosing schedules put brain effects to the test
- Can better posture strengthen the pelvic floor in osteoporosis?
- Magnetic pulses to the brain may help lung transplant patients sleep
- Magnetic pulses to the brain may help lung cancer patients sleep after surgery
- Magnetic pulses to the brain may help cancer patients sleep better
- Can a voice-based program empower blind women through menopause?